August 15, 2014
FDA Approves New CRC Screening Test
This week, the U.S. Food and Drug Administration (FDA) approved Cologuard, the first stool-based colon screening test that detects the presence of blood and altered DNA that may indicate certain kinds of abnormal growths related to colon cancer or precursors to cancer. In a study of 10,000 people of average risk for colon cancer, Cologuard reportedly was able to accurately detect cancer 92% of the time when it was present in an individual’s body.
May 28, 2014
FDA Approves First-Line Use of Vectibix®
Amgen recently announced that the FDA has approved the use of Vectibix as a first-line treatment for colorectal cancer. Since 2006, Vectibix has been used as a second-line treatment and with this recent advancement, colorectal cancer patients now have an additional treatment option earlier in their diagnosis.
March 26, 2014
New Colonoscopy Technology
A colonoscopy remains the best available procedure for detecting and removing pre-cancerous polyps; however, due to both technique and viewing area, studies have shown that some polyps may be missed. EndoChoice has developed a new colonoscope called Full Spectrum Endoscopy™ (Fuse™) that uses multiple cameras to create a panoramic view, allowing GIs to see more of the tract. (include FUSE image)
February 3, 2014
New Colon Exam Tool Approved
Today, Given Imaging Ltd announced that the U.S. Food and Drug Administration (FDA) has cleared PillCam® COLON as a new way to view the colon. The Colon Cancer Alliance welcomes PillCam COLON as an additional colon exam choice. When detected early, colon cancer is largely preventable. Through advancements like this, we’re one step closer to fulfilling our mission of knocking colon cancer out of the top three cancer killers. (include PillCam image)